Shares outstanding · 2011–2025
TG Therapeutics shares outstanding
155M−0.3% · FY2025
TG Therapeutics (TGTX) reported 155M in shares outstanding for fiscal 2025, −0.3% year on year.
| Fiscal year | Shares outstanding | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | 155M | −0.3% | Open → |
| FY20242024-12-31 | 156M | +2.9% | Open → |
| FY20232023-12-31 | 151M | +3.4% | Open → |
| FY20222022-12-31 | 146M | +2.2% | Open → |
| FY20212021-12-31 | 143M | +1.9% | Open → |
| FY20202020-12-31 | 141M | +28.5% | Open → |
| FY20192019-12-31 | 109M | +30.4% | Open → |
| FY20182018-12-31 | 83.9M | +14.7% | Open → |
| FY20172017-12-31 | 73.1M | +28.8% | Open → |
| FY20162016-12-31 | 56.8M | +5.0% | Open → |
| FY20152015-12-31 | 54.1M | +20.3% | Open → |
| FY20142014-12-31 | 44.9M | +31.0% | Open → |
| FY20132013-12-31 | 34.3M | +32.9% | Open → |
| FY20122012-12-31 | 25.8M | +409.9% | Open → |
| FY20112011-12-31 | 5.1M | — | Open → |
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +27.7%
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=TG Therapeutics shares outstanding |url=https://companiesranked.com/en/company/tg-therapeutics/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). TG Therapeutics shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/tg-therapeutics/shares-outstandingBibTeX
@misc{companiesranked-en-company-tg-therapeutics-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{TG Therapeutics shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/tg-therapeutics/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001437749-26-025955 · August 5, 2026
{{cite web |title=TG Therapeutics shares outstanding — 10-Q (0001437749-26-025955) |url=https://www.sec.gov/Archives/edgar/data/1001316/000143774926025955/tgtx20260630_10q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.